Innoscience: Its take on the Munich rulings
Innoscience's says that the current products are not affected by both rulings of the Munich Regional Court.
In the long-running patent battle between Infineon and Innoscience, the Chinese chipmaker is taking a positive view, regarding recent pair of rulings from the Munich Regional Court.
Innoscience says that its GaN power device products fall outside the scope of Infineon’s asserted German patents and may be commercialized in Germany without restriction.
According to Innoscience, these rulings are fully consistent with the final determination issued last month by the U.S. International Trade Commission (“ITC”), which found that Innoscience’s current products do not infringe Infineon’s asserted U.S. patent relating to packaging design (U.S. Patent No. 9,899,481).
The Munich case concerns the German counterparts of that same patent family, says Innoscience, which claims that in line with the ITC’s findings, the Munich Court found infringement only with respect to a limited set of legacy products – they are some packaged 650–700V transistors that had already been discontinued.
Due to this, Innoscience argues that any injunction granted would not apply to its current product portfolio. As a result, it claims that there is no impact to ongoing operations or its customers’ use of its products in Germany.
According to Innoscience, the decisions mark another significant milestone in its string of favourable outcomes across major jurisdictions. It is claimed that these outcomes follow recent success in China, where the company secured an injunction and damages award against Infineon, as well as its decisive victory at the ITC in the United States last month. Together, these rulings are said to reaffirm the legality of Innoscience’s current product portfolio and its ability to operate freely in key global markets.
While proceedings in Germany remain ongoing, including Innoscience’s invalidity challenges to the asserted German patent, the growing body of decisions across China, the United States, and Germany underscores that the global litigation campaign initiated by Infineon has not altered the competitive position of Innoscience’s core products, says the Chinese chipmaker. It says: To the contrary, independent judicial findings across multiple jurisdictions have consistently validated the robustness of Innoscience’s technology and reinforced market confidence in the company’s product compliance and innovation capabilities.
Innoscience says it remains committed to advancing its technology leadership and expanding its global footprint, delivering cutting-edge GaN solutions to customers worldwide in a fair and competitive marketplace.
